Delivery Order SPE2DB20D2104-SPE2DB24FMBYU

Award Date 9/19/24
Potential Completion Date 9/20/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,356.03, is for the delivery of telmisartan-amlodipine 80-10 medication in 30-count bottles. The contract has an ultimate completion date of November 16, 2023 and is a firm fixed-price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,562.45, is for Telmisartan-Amlodipine 80-10 30S tablets, a medication used to treat high blood pressure. The contract is a firm fixed-price delivery order with a completion date of January 24, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a $1,360.74 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Telmisartan-Amlodipine 40-5 mg tablets, a cardiovascular medication, with a period of performance through January 2, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award, valued at $1,530.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan-Amlodipine 40-10 30S, a medication, with a completion date of June 10, 2025. The contract is a Firm Fixed Price Delivery Order and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,992.64 firm fixed-price delivery order is for the supply of Telmisartan-Amlodipine 80-10 30S, a cardiovascular medication, with a period of performance through February 7, 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,475.38, is for the delivery of 4567502770 - TELMISARTAN-AMLODIPINE 80-5 MG 30S, a cardiovascular medication. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Telmisartan-Amlodipine 80-10 30s medication. The contract has a ceiling value of $2,323.32 and an ultimate completion date of July 31, 2024. The award is not associated with a set-aside program. Amerisourcebergen, through its Corporate Office division, has been a significant supplier of pharmaceutical products and medical...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,676.43 Firm Fixed Price Delivery Order contract is for the provision of Telmisartan-Amlodipine 80-10 30S, a cardiovascular medication, with a completion date of June 18, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4563118190 - Telmisartan-Amlodipine 40-10 30 tablets, with a firm fixed price ceiling value of $1,644.20 and a completion date of December 18, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,076.23, is for the delivery of telmisartan-amlodipine 40-5 mg tablets. This order is placed under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. The IDC serves as a primary vehicle...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FMBYU
    Delivery Order

This is a $1,460.31 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Telmisartan-Amlodipine 80-10 30S, a prescription medication. It is a firm-fixed-price contract with a period of performance ending on September 20, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of medical commodities from Amerisourcebergen to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/19/24, 9:31 AM